New Delhi: The Delhi High Court in January 2026 restored the Centre's ban on certain triple-drug fixed dose combinations (FDCs) used in the treatment of type 2 diabetes, holding that…
Trial results indicate that in adults 65 years and older, the high-dose inactivated influenza vaccine (HD-IIV) consistently reduced cardiorespiratory, cardiovascular, and influenza-related hospitalizations compared with the standard-dose vaccine (SD-IIV), irrespective…
Itanagar: In a significant boost to healthcare services in Arunachal Pradesh, the Indian Army has set up the state's first-ever state-of-the-art Intrauterine Insemination (IUI) Centre at Tenga in West Kameng…
South Korea: A new study published in BMJ Open has found that maintaining normal systolic blood pressure (SBP) below 120 mmHg significantly slows the progression of coronary artery calcification (CAC)—a…
Trump's most consequential proposals would require action from Congress.
The former CEO of Emergent BioSolutions was accused of insider trading by the New York State attorney general in connection with a Covid-era contract.
New Delhi: The Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO) has recommended grant of permission to Johnson & Johnson Pvt. Ltd. to import and market…
Women aged younger than 45 years who experience menopause are at a higher risk of coronary heart disease and stroke. However, despite such diabetes-related risk factors as increased fat and…
According to a Phase I study led by researchers at The University of Texas MD Anderson Cancer Center, published today in Nature Medicine, the novel monoclonal antibody linavonkibart demonstrated the…
Subcutaneous anifrolumab (Saphnelo) added to standard therapy significantly improves treatment outcomes in patients with systemic lupus erythematosus (SLE). In the phase 3 TULIP-SC trial, anifrolumab met its primary BICLA endpoint…